Moleculin Biotech, Inc. (MBRX)
2.20
-0.03
(-1.35%)
USD |
NASDAQ |
Apr 02, 10:51
Moleculin Biotech Total Assets (Quarterly) : 22.13M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Imunon, Inc. | 12.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.12M |
| Shareholders Equity (Quarterly) | 15.01M |
| Debt to Equity Ratio | 0.0239 |
| Current Ratio | 1.413 |
| Net Debt Paydown Yield | 0.35% |